drugset / Trial / NCT06415461

A Study Assessing the Safety of Cord Blood Product in Sacroiliac Joint Syndrome (SIJ)

NCT06415461 ↗

Phase 1 Active not recruiting 9 enrolled University of Florida Cord for Life, Inc. · collab
Non-randomizedSequentialOpen-labelTreatment

Summary

This is a Phase 1 trial. The overall objective is to evaluate the safety and potential efficacy effect of specific type of umbilical cord blood product (CFL001), which, other than specific modifications in manufacturing to render it compatible with current Good Manufacturing Practice (cGMP), is essentially similar to that reported in real-world experience.

Timeline

Start
2024-05-10
Primary completion
2027-01-15
Completion
2028-03-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject PremierMaxCB®-Platinum Unknown 3e+07 cells —
Subject PremierMaxCB®-Platinum Unknown 6e+07 cells —
Subject PremierMaxCB®-Platinum Unknown 9e+07 cells —